Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 January 2022 | Story Ruan Bruwer | Photo Supplied
Keenan Carelse.

University of the Free State (UFS) Alumni may be based all around the world, but the United Kingdom (UK) Alumni Chapter aims to reconnect with all those members.

The UK Chapter is a hub of a developing UFS international programme. “We want to provide an opportunity for alumni to share their university experiences with wider audiences,” explains Carmenita Redcliffe Paul, Assistant Director: Alumni Relations and Business Development at the UFS.

Platform to celebrate successes

“The programme aims to provide a platform to alumni to celebrate their successes and provide a window to the landscape of the life and times of the university and the people who shaped it.”

“We also want to celebrate the diversity of our former students and the many touchpoints which unite them.”

Two key projects, Global Citizen and Voices from the Free State, came to life as a result of the collective collaboration of this chapter. The Global Citizen invites people in a series of “courageous conversations” to rethink their relationship with the world. Voices from the Free State is a series of personal podcast narratives by outstanding alumni wherein they reflect their experiences at the UFS. They tell their stories and explain how their university years shaped their future and paved the way to their respective successes.

Relevant association with the UFS

“Furthermore, they motivate why their ongoing association with the UFS is still relevant and important,” says Redcliffe Paul.

The UK Alumni Chapter is led by alumni Francois van Schalkwyk and Keenan Carelse and supported by Adrienne Hall.

Redcliffe Paul says Carelse and Van Schalkwyk have been instrumental in the Voices from the Free State initiative as they are strategically and operationally invested. They create and co-host the podcast series.

Van Schalkwyk is an entrepreneur and innovator consulting with clients globally. Carelse is employed in the healthcare sector in the UK.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept